I n order to give the best care to patients and families, paediatricians need to integrate the highest quality scientific evidence with clinical expertise and the opinions of the family. 1 Archimedes seeks to assist practising clinicians by providing ''evidence based'' answers to common questions which are not at the forefront of research but are at the core of practice. In doing this, we are adapting a format which has been successfully developed by Kevin MacawayJones and the group at the Emergency Medicine Journal-''BestBets''.
A word of warning. The topic summaries are not systematic reviews, through they are as exhaustive as a practising clinician can produce. They make no attempt to statistically aggregate the data, nor search the grey, unpublished literature. What Archimedes offers are practical, best evidence based answers to practical, clinical questions.
The format of Archimedes may be familiar. A description of the clinical setting is followed by a structured clinical question. (These aid in focusing the mind, assisting searching, 2 and gaining answers. 3 ) A brief report of the search used follows-this has been performed in a hierarchical way, to search for the best quality evidence to answer the question. 4 A table provides a summary of the evidence and key points of the critical appraisal. For further information on critical appraisal, and the measures of effect (such as number needed to treat, NNT) books by Sackett 5 and Moyer 6 may help. To pull the information together, a commentary is provided. But to make it all much more accessible, a box provides the clinical bottom lines.
The electronic edition of this journal contains extra information to each of the published Archimedes topics. The papers summarised in tables are linked, by an interactive table, to more detailed appraisals of the studies. Updates to previously published topics will be linked to the original article when they are available.
Electronic-only topics that have been published on the BestBets site (www.bestbets.org) and may be of interest to paediatricians include: N Do we need to give steroids in children with Bell's palsy? N Is plain radiography indicated as 1st choice imaging modality in children with non-traumatic back pain?
Readers wishing to submit their own questions-with best evidence answers-are encouraged to review those already proposed at www.bestbets.org. If your question still hasn't been answered, feel free to submit your summary according to the Instructions for Authors at www.archdischild.com. Three topics are covered in this issue of the journal. Bronchiolitis: evidence based challenge It's the end of winter in the northern hemisphere, and paediatricians at the clinical coalface may be a little bored with the unending stream of small children sounding like old smokers. Bronchiolitis provides those who are interested in practicing evidence based medicine a great challenge: it is a common problem, desperately miserable for the children and families affected, and asks a multitude of clinical questions. How should we diagnose this condition? Should we investigate the children affected? How should we intervene to improve their lot-both generally and specifically? What is the outcome over time-and in the long term?
Archimedes has frequently taken up the challenge of offering some aspects of bronchiolitis care to a review of their evidence. [1] [2] [3] [4] We would like to take this time to point out some additional and pertinent evidence based resources. On the BestBets site you can read in more detail questions of the effectiveness of DNAse, and monteleukast 5 6 (though we are still not aware of any research on the utility of dropping saline into a small child's nostrils). An evidence based medicine journal contains a summary of a recent wide ranging systematic review of standard therapeutic options (bronchodilators and steroids). 7 An original review of the usefulness of diagnostic testing is also available (though not as readable). 8 We would also urge readers not to forget that all ''snuffle and stop breathing'' episodes are not bronchiolitis, 9 and offer some alternative approaches to the treatment of pertussis.
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And finally we'd like to offer a further challenge. Can we advance studies of bronchiolitis beyond enrolling only tens or hundreds of infants among the thousands that pour through our fingers, and achieve such numbers in therapeutic trials that we may truly be able to distinguish which therapies (if any) are helpful? I t is mid-December. As a paediatric SHO working a busy evening shift in a district general hospital, you are called to re-site the intravenous cannula of an infant with bronchiolitis. This is the fifth time that day you have been asked to perform such a task, and you approach the distressed, chubby infant with a sense of dread. Of the 20 children on the ward, 15 have bronchiolitis and 10 are on intravenous fluids. You consider how much distress placement and regular replacement of the cannulae causes these infants, and wonder if fluids could be given safely by another route. Would rehydration using a nasogastric tube (NGT) be appropriate? 
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Structured clinical question
Commentary
Maintaining optimal hydration is an important component in the management of bronchiolitis. Practice varies between units as to the route of administration. There is some evidence 1 that a NGT increases airway resistance in small preterm neonates, but not in older heavier ones. 2 Total tidal volume in well neonates is not affected by an NGT. 3 However, it is difficult to extrapolate from these studies to the clinical significance of an NGT in older, larger children with bronchiolitis. Expert opinion varies. Nicolai and Pohl 4 and Sporik 5 argue ''from first principles'' that the nasogastric (NG) route be avoided because of the theoretical risk of increased airway resistance. However based on the same studies cited by Sporik, Milner came to the conclusion that the NG route is acceptable in infants over 2 kg.
The case series reported by Sammartino et al and Vogel et al show that there is widespread use of the NG route in many units. 6 7 However, no conclusions can be drawn from their data regarding the safety of NG fluids versus the intravenous route.
No studies were identified assessing the likelihood of electrolyte disturbance in children with bronchiolitis given intravenous rather than nasogastric fluids.
In infants with bronchiolitis, there is no good quality evidence that rehydration by the NG route is more or less safe than via the intravenous route. A randomised controlled trial is needed. A 2 week old infant, born at 36 weeks gestation was admitted to the paediatric ward in November with a 24 hour history of runny nose, cough, and episodes of shallow breathing and apnoeas. This was thought to be due to bronchiolitis, and the consultant paediatrician suggested starting the baby on caffeine (theophylline derivative with less side effects). As the resident middle grade doctor, I knew that caffeine has been used widely in neonatal units for apnoea of prematurity, but I wondered if there was any evidence for its use in this clinical situation.
Structured clinical question In infants with bronchiolitis [patient] does caffeine [intervention] reduce or prevent apnoeas [outcome]?
Search strategy and outcome Cochrane database of systematic reviews: No directly relevant study found, but there was one systematic review on the efficacy of methylxanthines in reducing apnoea of prematurity 1 and another systematic review on the prophylactic use of caffeine to prevent postoperative apnoea following general anaesthesia in ex-preterm infants. and apnoea/apnea and caffeine/xanthine/methylxanthine/ phosphodiesterase inhibitors/theophylline There was one retrospective review 3 and two case reports 4 5 (in the form of letters to the editor) directly addressing the problem (table 2). There was also one randomised controlled trial on the usefulness of aminophylline in reducing apnoeas and intubation in term infants during prostaglandin E1 infusion. 
Commentary
Recurrent apnoea is a common problem in otherwise well preterm infants. By term equivalent age, infants have usually ''outgrown'' their tendency to spontaneous apnoea. However, with an additional stress, such as infection (for example, bronchiolitis) or administration of drugs that depress the central nervous system (for example, general anaesthesia, prostaglandin), then apnoea and oxygen desaturations can recur.
Caffeine is recognised to reduce apnoea and the need for mechanical ventilation in preterm infants with apnoea of prematurity. 1 In addition caffeine prevents apnoea, bradycardia, and episodes of desaturation in growing preterm infants following general anaesthesia, 2 while aminophylline, which is another widely used theophylline derivative, was found to be effective for the prevention of apnoea and intubation during prostaglandin E1 infusion in term infants 6 (table 3). While these data are supportive, there may be significant differences in the mechanism of apnoea in general anaesthesia and viral induced apnoea.
We could only find three reports 3-5 involving a total of 10 infants, all of whom were born preterm and presented with bronchiolitis associated apnoeas approximately around term equivalent age. These reports have concluded that theophylline derivatives are effective in reducing the incidence of apnoeas and avoided the need for mechanical ventilation in this clinical situation (table 1) .
Caffeine has a more favourable therapeutic index than aminophylline. No major adverse effects were reported from the studies included in the systematic reviews. 1 2 Jitteriness, tachycardia, and raised blood glucose are the common side effects, but routine drug level monitoring is not necessary at standard dosage. 7 While these three reports claim that the use of caffeine helped avoid intubation in infants with viral infection induced apnoea, there are no data from randomised controlled trials confirming these benefits. As intubation for apnoea in bronchiolitis is uncommon, a large multicentre trial would be needed.
Are newer macrolides effective in eradicating carriage of pertussis? From history, you note that he is allergic to penicillin and has been given erythromycin for a previous episode of 6 mg/kg iv aminophylline followed by 2 mg/kg iv 8 hourly for 72 hours
CLINICAL BOTTOM LINE
N In addition to its proven efficacy in apnoea of prematurity, caffeine has also been shown to reduce the incidence of apnoea in ex-preterm infants following general anaesthesia and in term infants following prostaglandin infusion.
N There is only limited evidence from case reports for the use of caffeine in infants presenting with bronchiolitis associated apnoeas. Commentary Antimicrobials are usually administered when pertussis is suspected or confirmed. If the disease is already established (paroxysmal phase), antibiotics have little or no effect on the clinical course of the illness except to render the patient noninfectious to others. This is important, so as to limit the spread of infection especially to the unimmunised and young infants. A 10-14 day course of erythromycin is the long established treatment for whooping cough. 1 It is known to reduce transmission and hasten clearance of B pertussis. However, gastrointestinal side effects seem quite limiting in a large proportion of patients treated with it. 7 This may have a bearing in ensuring compliance. Newer macrolides-clarithromycin and azithromycin-are superior to erythromycin in terms of absorption, acid stability, and tissue penetration. They have longer half-lives, enabling less frequent dosing and shorter treatment courses. 5 They are also known to have fewer side effects.
From the available evidence it can be seen that the newer macrolides are at least as effective as erythromycin in eradicating B pertussis infection. A significant reduction in adverse gastrointestinal side effects and a better compliance have been shown. No serious side effects have been observed with these agents so far. Transient elevation in alanine aminotransferase (ALT) has been shown in one study. 
